Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms

Oncology

Volumn 66, Issue 6, 2004, Pages 468-475

  Yamamoto, Shinji ^a   Tomita, Yasuhiko ^a   Nakamori, Shoji ^a   Hoshida, Yoshihiko ^a   Iizuka, Norishige ^a   Okami, Jiro ^a   Nagano, Hiroaki ^a   Dono, Keizo ^a   Umeshita, Koji ^a   Sakon, Masato ^a   Ishikawa, Osamu ^b   Ohigashi, Hiroaki ^b   Aozasa, Katsuyuki ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Ki 67 labeling index; Pancreatic endocrine neoplasms; Valosin containing protein

Indexed keywords

KI 67 ANTIGEN; MARKER; MESSENGER RNA; PROTEIN P97;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; PANCREAS CANCER; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TUMOR CELL;

ADULT; AGED; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; ODDS RATIO; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 5644244838     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079501     Document Type: Article

References (23)

1. Klopel G, IntVeld PA, Komminoth P, Heitz PU: The endocrine pancreas; in Kovacs K, Asa SL (eds): Functional Endocrine Pathology. Oxford, Blackwell, 1998, pp 415-487.
2. Hockwald SN, Conlon KC, Brennan MF: Nonfunctioning pancreatic islet cell tumors; in Doherty GM (ed): Surgical Endocrinology. Philadelphia, Lippincott Williams and Wilkins, 2001, pp 361-373.
3. Solcia E, Sessa F, Rindi G: Pancreatic endocrine tumors: General concepts, nonfunctioning tumors and tumors with uncommon function; in Dayal Y (ed): Endocrine Pathology of the Gut and Pancreas. Boca Raton, CRC, 1991,pp 105-131.
4. Broughan TA, Leslie JD, Soto JM, Hermann RE: Pancreatic islet cell tumors. Surgery 1986;99:671-678.
5. White TJ, Edney JA, Thompson JS, Karrer FW, Moor BJ: Is there a prognostic difference between functional and nonfunctional islet cell tumors? Am J Surg 1994;168:627-630.
6. Gumbs AA, Moore PS, Falconi M, Bassi C, Beghelli S, Modlin I, Scarpa A: Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol 2002;81:45-53.
7. Hochwald SN, Zee S, Conlon KC, Colleoni R, Louie O, Brennan MF, Klimstra DS: Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;20:2633-2642.
8. La Rosa S, Sessa F, Capella C, Riva C, Leone BE, Klersy C, Rindi G, Solcia E: Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch 1996;429:323-333.
9. Pelosi G, Bresaola E, Bogina G, Pasini F, Rodella S, Castelli P, Iacono C, Serio G, Zamboni G: Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27:1124-1134.
10. Yantiss RK, Chang HK, Farraye FA, Compton CC, Odze RD: Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol 2002;26:893-901.
11. Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H, Aozasa K: VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 2002;93:296-304.
12. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC: Involvement of valosin-containing protein, an ATPase co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 1998;273:3562-3573.
13. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M, Aozasa K: Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 2003;21:447-452.
14. Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T, Yano M, Nakamori S, Sakon M, Monden M, Aozasa K: Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol 2003;21:2537-2544.
15. Yamamoto S, Tomita Y, Hoshida Y, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O, Ohigashi H, Nakamori S, Monden M, Aozasa K: Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol 2004;11:165-172.
16. Heid CA, Stevens J, Livak KJ, Williams PM: Real time quantitative PCR. Genome Res 1996;6:986-994.
17. Holland PM, Abramson RD, Watson R, Gelfand DH: Detection of specific polymerase chain reaction product by utilizing the 5′ → 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276-7280.
18. Viale G, Doglioni C, Gambacorta M, Zamboni G, Coggi G, Bordi C: Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Cancer 1992;70:2268-2277.
19. Beghelli S, Pelosi G, Zamboni G, Falconi M, Iacono C, Bordi C, Scarpa A: Pancreatic endocrine tumours: Evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. J Pathol 1998;186:41-50.
20. Mayo MW, Baldwin AS: The transcription factor NF-kappaB: Control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000;1470:M55-M62.
21. Beg AA, Baltimore D: An essential role for NFkappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
22. Andela VB, Schwarz EM, Puzas JE, O'Keefe RJ, Rosier RN: Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 2000;60:6557-6562.
23. Muller JM, Meyer HH, Ruhrberg C, Stamp GW, Warren G, Shima DT: The mouse p97 (CDC48) gene. Genomic structure, definition of transcriptional regulatory sequences, gene expression, and characterization of a pseudogene. J Biol Chem 1999;274:10154-10162.